HYPERHEP B S/D
HYPERHEP B S/D
Discontinued
DIN Number
02379473
Drug Class
Human
Market Date
N/A
Company
HC
基立福
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02379473
AIG Number0114080002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB04 HEPATITIS B IMMUNOGLOBULIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HEPATITIS B IMMUNOGLOBULIN (HUMAN)Active
Strength: 220 UNIT / ML
Monograph: HEPATITIS B IMMUNOGLOBULIN (HUMAN)